// App-Quantinova.ai

4267 : Integrated genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups

Researchers

Presenter

  • Dolores H. Lopez-Terrada

Principal Investigators

  • Pavel Sumazin

  • Yidong Chen

  • Murali Chintagumpala

  • Rebecka M. Meyers

  • Milton J. Finegold

  • Gail Tomlinson

  • Donald W. Parsons

  • Lisa Trevino

  • Stephen Sarabia

  • Oliver Hampton

  • Kayuri Patel

  • Toni-Ann Mistretta

  • Barry Zorman

  • Sarah Comerford

  • David Wheeler

Medical Centers

  • University of Utah, Salt Lake City, UT

  • The University of Texas at Dallas, TX

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • Baylor College of Medicine, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Hepatoblastoma

  • Solid malignancies

Biomarkers

  • Adenomatous Polyposis Coli

  • Alpha-fetoprotein

  • Neurogenic locus notch homolog protein 1

  • beta-catenin

  • Phosphatase and tensin homolog

  • Dickkopf-Related Protein 1

  • Glypican-3

  • elta Like Non-Canonical Notch Ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final